Morgan Stanley’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.7M | Buy |
2,238,252
+1,797,563
| +408% | +$42.4M | ﹤0.01% | 1871 |
|
|
2025
Q1 | $10.6M | Buy |
440,689
+112,174
| +34% | +$2.69M | ﹤0.01% | 3281 |
|
|
2024
Q4 | $13.9M | Sell |
328,515
-12,561
| -4% | -$531K | ﹤0.01% | 3092 |
|
|
2024
Q3 | $15.1M | Buy |
341,076
+35,638
| +12% | +$1.58M | ﹤0.01% | 3080 |
|
|
2024
Q2 | $11.1M | Sell |
305,438
-1,231,352
| -80% | -$44.6M | ﹤0.01% | 3247 |
|
|
2024
Q1 | $66.3M | Sell |
1,536,790
-452,890
| -23% | -$19.5M | 0.01% | 1503 |
|
|
2023
Q4 | $30.6M | Buy |
1,989,680
+1,074,934
| +118% | +$16.5M | ﹤0.01% | 2948 |
|
|
2023
Q3 | $12.5M | Sell |
914,746
-53,299
| -6% | -$731K | ﹤0.01% | 2907 |
|
|
2023
Q2 | $15.5M | Buy |
968,045
+927,377
| +2,280% | +$14.9M | ﹤0.01% | 2730 |
|
|
2023
Q1 | $316K | Buy |
40,668
+25,115
| +161% | +$195K | ﹤0.01% | 5491 |
|
|
2022
Q4 | $301K | Sell |
15,553
-7,407
| -32% | -$143K | ﹤0.01% | 5493 |
|
|
2022
Q3 | $489K | Buy |
22,960
+19,495
| +563% | +$415K | ﹤0.01% | 5283 |
|
|
2022
Q2 | $47K | Sell |
3,465
-15,053
| -81% | -$204K | ﹤0.01% | 6644 |
|
|
2022
Q1 | $435K | Sell |
18,518
-8,173
| -31% | -$192K | ﹤0.01% | 5496 |
|
|
2021
Q4 | $714K | Buy |
26,691
+4,685
| +21% | +$125K | ﹤0.01% | 5321 |
|
|
2021
Q3 | $382K | Buy |
22,006
+20,222
| +1,134% | +$351K | ﹤0.01% | 5654 |
|
|
2021
Q2 | $24K | Buy |
+1,784
| New | +$24K | ﹤0.01% | 6947 |
|